Durham, NC – EpiCypher®, a leader in epigenomics innovation, announces the launch of CUTANA® meCUT&RUN and Multiomic CUT&RUN, two novel DNA methylation sequencing technologies advancing the frontiers of genomic research and drug discovery. These tools build upon EpiCypher’s proven CUT&RUN platform – a targeted nuclease strategy that has revolutionized chromatin profiling by enabling high-resolution mapping […]

Expanded suite of consumables, instruments and services designed to empower researchers and accelerate next-generation drug development Ninety posters and presentations at AACR powered by the Standard BioTools proteomic portfolio to advance cancer research from target discovery to clinical development SOUTH SAN FRANCISCO, Calif. — Standard BioTools Inc. (NASDAQ: LAB) today announced the launch of new and enhanced […]

Adds to robust offering of NGS tools enabling exome sequencing, whole genome sequencing, RNA sequencing, deep sequencing for liquid biopsy research and MRD, and methylation detection Diverse portfolio of adapter sets now includes industry leading number of unique indexes at 3,072 HT UDI Adapters Enables multiplexing and high throughput sequencing SOUTH SAN FRANCISCO, Calif. —  […]

Latest release supports the use of MS-based purity assays from R&D through to regulated environments Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the latest release of Genedata Expressionist®, the industry-leading platform for streamlining and automating the characterization and quality monitoring of biotherapeutics using Mass Spectrometry (MS). […]

SCOTTS VALLEY, Calif. — Dovetail Genomics, a leading innovator in genomic solutions, today announced an expanded comprehensive analysis solution for somatic variation detection, addressing the challenge of identifying structural variants (SVs) using NGS platforms. The solution offers ultra-sensitive discovery of SVs at base-pair resolution down to 1% variant allele frequency (VAF), and biologically meaningful interpretation of SVs […]

Amsbio has launched a new range of Deubiquitinating (DUB) enzyme assay kits supplied in a convenient and easy-to-use 96-well assay format. With minimal setup required and no need for substrate preparation, these ready-to-use kits accelerate routine DUB activity assays without compromising data quality. Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in […]

Automated Density Gradient Preparation Reduces Run Times by up to 75% INDIANAPOLIS – Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the launch of the OptiMATE Gradient Maker, a groundbreaking instrument designed to automate the process of density gradient ultracentrifugation (DGUC). The new system accelerates purification processes […]

bioMérieux has launched the WatchFire molecular testing solution, a PCR test to detect viruses and bacteria in wastewater and respond to potential infectious disease outbreaks, according to the company. RT’s Three Key Takeaways Product Launch: bioMérieux has introduced the WatchFire molecular testing solution, a 22-target PCR test running on the Biofire FilmArray Torch, designed to detect […]

The EYRA protein analysis platform will significantly reduce costs and hassle associated with other solutions, aiding researchers all over the world within immunology, infectious diseases and inflammation. Stockholm, Sweden: Mabtech, a Swedish life science tools company developing immunoassay biochemical tests for research, announces a new highly innovative image-based multiplex platform in close collaboration with research […]

Automated normalization of multiplex imaging replaces manual methods to reduce variability, enabling biopharma researchers to accurately identify novel spatial biomarkers and scale up biomarker validation across large cohorts At AACR, Nucleai will showcase new spatial data interpretation tools and posters highlighting Nucleai’s platform for derisking ADC and immunotherapy drug development Chicago – Nucleai, an AI-powered […]